Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120

Journal of Peptide Research

Volumn 54, Issue 1, 1999, Pages 32-42

  Ferrer, M ^a   Sullivan, B J ^b   Godbout, K L ^b   Burke, E ^b   Stump, H S ^b   Godoy, J ^b   Golden, A ^b   Profy, A T ^b   Van Schravendijk, Maria R ^b,c  

^a HARVARD UNIVERSITY   (United States)

^b Procept Inc   (United States)

^c ARIAD PHARMACEUTICALS INC   (United States)

Author keywords

Conformation; Epitope; HIV 1 gp120; Monoclonal antibody; Peptide; Viral fusion

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD4; BINDING SITES; CIRCULAR DICHROISM; CONSERVED SEQUENCE; EPITOPE MAPPING; EPITOPES; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV-1; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032840985     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.1999.00082.x     Document Type: Article

References (43)

1. 4 receptor and its central role in promotion of HIV-1 infection. Microbiol. Rev. 59, 63-93.
2. 2. McKeating, J.A. (1996) Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? J. Gen. Virology 77, 2905-2919.
3. 3. Chan, D.C. & Kim, P.S. (1998) HIV entry and its inhibition. Cell 93, 681-684.
4. 4 atomic structure. J. Exp. Med. 176, 507-517.
5. 5. Littman, D.R. (1998) Chemokine receptors: keys to AIDS pathogenesis? Cell 93, 677-680.
6. 4 binding. J. Exp. Med. 174, 407-415.
7. 4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J. Virol. 67, 3818-3825.
8. 4 receptor and a neutralizing human antibody. Nature 393, 648-659.
9. 9. Moore, J.P. & Sodroski, J. (1996) Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J. Virol. 70, 1863-1872.
10. 10. Ditzel, H.J., Parren, P.W.H.I., Binley, J.M., Sodroski, J., Moore, J.P., Barbas, C.F.I. & Burton, D.R. (1997) Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries. J. Mol. Biol. 267, 684-695.
11. 11. Wyatt, R., Kwong, P.D., Desjardins, E., Sweet, R.W., Robinson, J., Hendrickson, W.A. & Sodroski, J.G. (1998) The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393, 705-711.
12. 12. Schulz, T.F., Jameson, B.A., Lopalco, L., Siccardi, A.G., Weiss, R.A. & Moore, J.P. (1992) Conserved structural features in the interaction of retroviral surface and transmembrane glycoproteins. AIDS Res. Hum. Retroviruses 8, 1571-1580.
13. 13. Helseth, E., Olshevsky, U., Furman, C. & Sodroski, J. (1991) Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 65, 2119-2123.
14. 14. Harlow, E. & Lane, D. (1988) Antibodies. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 139-243; 522-525.
15. 15. Lian, L.Y., Barsukov, I.L., Derrick, J.P. & Roberts, G.C.K. (1994) Mapping the interactions between streptococcal protein G and the Fab fragment of IgG in solution. Nature Struct. Biol. 1, 355-357.
16. 16. Page, K.P., Landau, N.R. & Littman, D.R. (1990) Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64, 5270-5276.
17. 17. Schmidt, T.G.M. & Skerra, A. (1993) The random peptide library-assisted engineering of a C-terminal affinity peptide, useful for the detection and purification of a functional Ig Fv fragment. Protein Eng. 6, 109-122.
18. 18. Golden, A., Austen, D.A., van Schravendijk, M.R., Sullivan, B.J., Kawasaki, E.S. & Osburne, M.S. (1998) Effect of promoters and signal sequences on the production of secreted HIV-1 gp120 in the baculovirus system. Protein Expr. Purif. 14, 8-12.
19. 4. J. Immunol. Methods 210, 215-225.
20. 20. Durda, P.J., Bacheler, L., Clapham, P., Jenoski, A.M., Leece, B., Matthews, T.J., McKnight, A., Pomerantz, R., Rayner, M. & Weinhold, K.J. (1990) HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide. AIDS Res. Hum. Retroviruses 6, 1115-1123.
21. 21. Schuck, P. (1997) Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. Annu. Rev. Biophys. Biomol. Struct. 26, 541-566.
22. 22. VanCott, T.C., Bethke, F.R., Kalyanaraman, V., Burke, D.S., Redfield, R.R. & Birx, D.L. (1994) Preferential antibody recognition of structurally distinct HIV-1 gp120 molecules. J. AIDS 7, 1103-1115.
23. 23. Pacholczyk, T. & Sweadner, K.J. (1997) Epitope and mimotope for an antibody to the Na,K-ATPase. Protein Sci. 6, 1537-1548.
24. 24. Pinilla, C., Appel, J.R. & Houghten, R.A. (1993) Functional importance of amino acid residues making up peptide antigenic determinants. Mol. Immunol. 30, 577-585.
25. 25. Andersen, H.H. & Tong, H. (1997) Empirical parameterization of a model for predicting peptide helix/coil equilibrium populations. Protein Sci. 6, 1920-1936.
26. 26. Myers, J.K., Pace, C.N. & Scholtz, J.M. (1997) A direct comparison of helix propensity in proteins and peptides. Proc. Natl Acad. Sci. USA 94, 2833-2837.
27. 4 receptor binding by the env protein of human immunodeficiency virus type 1. J. Virol. 62, 3695-3702.
28. 5 region mimics the HLA class I α1 peptide-binding domain. Eur. J. Immunol. 23, 2016-2021.
29. 29. Zolla-Pazner, S., O'Leary, J., Burda, S., Gorny, M.K., Kim, M., Mascola, J. & McCutchan, F. (1995) Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J. Virol. 69, 3807-3815.
30. 30. Appel, J.R., Pinilla, C., Niman, H. & Houghten, R. (1990) Elucidation of discontinuous linear determinants in peptides. J. Immunol 144, 976-983.
31. 31. Hodges, R.S., Heaton, R.J., Parker, J.M.R., Molday, L. & Molday, R.S. (1988) Antigen-antibody interaction: synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin. J. Biol. Chem. 263, 11768-11775.
32. 32. Shoham, M. (1993) Crystal structure of an anticholera toxin peptide complex at 2.3 A. J. Mol. Biol. 232, 1169-1175.
33. 33. Churchill, M.E.A., Stura, E.A., Pinilla, C., Appel, J.R., Houghten, R.A., Kono, D.H., Balderas, R.S., Fieser, G.G., Schulze-Gahmen, U. & Wilson, I.A. (1994) Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9: comparison of two different antibodies bound to the same peptide antigen. J. Mol. Biol. 241, 534-556.
34. 34. Smith-Gill, S.J. (1994) Protein epitopes: functional vs. structural definitions. Res. Immunol. 145, 67-70.
35. 3 loop epitopes recognized by monoclonal antibodies. Mol. Immunol. 33, 737-745.
36. 36. Hansen, J.E., Lund, O., Nielsen, J.O., Brunak, S. & Hansen, J.E.S. (1996) Prediction of the secondary structure of HIV-1 gp120. Proteins: Struct. Func. Genet. 25, 1-11.
37. 37. Zeder-Lutz, G., Altschuh, D., Geysen, M.H., Trifilieff, E., Sommermeyer, G. & Van Regenmortel, M.H.V. (1993) Monoclonal antipeptide antibodies: affinity and kinetic rate constants measured for the peptide and the cognate protein using a biosensor technology. Mol. Immunol. 30, 145-155.
38. 38. Stern, B., Denisova, G., Buyaner, D., Raviv, D. & Gershoni, J.M. (1997) Helical epitopes determined by low-stringency antibody screening of a combinatorial peptide library. FASEB J. 11, 147-153.
39. 39. Reymond, M.T., Merutka, G., Dyson, H.J. & Wright, P.E. (1997) Folding propensities of peptide fragments of myoglobin. Protein Sci. 6, 706-716.
40. 4. AIDS 4, 307-315.
41. 41. Scandella, C.J., Kilpatrick, J., Lidster, W., Parker, C., Moore, J.P., Moore, G.K., Mann, K.A., Brown, P., Coates, S. & Chapman, B. (1993) Non-affinity purification of recombinant gp120 for use in AIDS vaccine development. AIDS Res. Hum. Retroviruses 9, 1233-1244.
42. 42. Wyatt, R., Desjardin, E., Olshevsky, U., Nixon, C., Binley, J., Olshevsky, V. & Sodroski, J. (1997) Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein. J. Virol. 71, 9722-9731.
43. 4 and coreceptors. J. Biol. Chem. 273, 404-409.